A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia
- 3 July 2004
- journal article
- clinical trial
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 12 (10) , 725-730
- https://doi.org/10.1007/s00520-004-0658-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patientsSupportive Care in Cancer, 2002
- A novel approach to maintain planned dose chemotherapy on time: a decision-making tool to improve patient careEuropean Journal Of Cancer, 2000
- Chemotherapy dose reduction and delay in clinical practiceEuropean Journal Of Cancer, 2000
- Colony-stimulating factors and antibiotics—a new prospect in treating infectious diseases?Clinical Microbiology & Infection, 1998
- Prophylaxis with Fluoroquinolones for Bacterial Infections in Neutropenic Patients: A Meta-AnalysisClinical Infectious Diseases, 1996
- G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluationJournal of Clinical Pharmacy & Therapeutics, 1996
- Management of Fever in Patients with Cancer and Treatment-Induced NeutropeniaNew England Journal of Medicine, 1993
- Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyEuropean Journal Of Cancer, 1993
- Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989